Kim M K, Chung S J, Lee M H, Shim C K
College of Pharmacy, Seoul National University, Korea.
J Microencapsul. 1998 Jan-Feb;15(1):21-9. doi: 10.3109/02652049809006832.
The in-vivo cutaneous absorption of hydrocortisone was examined following topical application of hydrocortisone-containing liposomes. The formulation was applied onto the skin (1.0 cm2) of the hairless mouse (at a dose of 0.1 mg hydrocortisone) in the presence and absence of occlusion, and temporal profiles of the drug in the skin (stratum corneum and viable skin) were monitored. Under the non-occluded condition, the drug amount in the stratum corneum and viable skin reached its maximum within 1 h, and then decreased rapidly. Gelation of the liposomes by complete dehydration of the formulation under non-occlusion, which may prevent partition of the drug into the skin, appears to be a cause of the rapid decrease. Under the occluded condition, the drug amount in the skin was sustained although it then decreased dramatically compared with that under the non-occlusion (i.e. approximately 1/22 for stratum corneum and 1/8 for viable skin at 1 h, for example). A prevention of gelation of the liposomes by occlusion appears to be a potential mechanism of the maintenance of the drug concentration in the skin. The dramatic decrease in drug content in the skin may be attributed to the reduced partition of hydrocortisone, a hydrophobic drug, from the liposomes into the hydration-maintained stratum corneum under occlusion. In both application conditions, the concentration of hydrocortisone in the hydrophilic viable skin layer was markedly lower than that in the stratum corneum, indicating that partitioning between these tissues is a primary determinant of hydrocortisone reaching viable skin tissue. The estimated penetration depth of the drug into the stratum corneum was not affected significantly by the application conditions. These results demonstrate that excessive dehydration (non-occlusion) is not desirable for the prolonged delivery of hydrocortisone from liposomes into the skin. They also indicate that either hydration of the dosed skin (occlusion) is not preferable for the efficient delivery of hydrocortisone from the liposomes to the skin, especially to the viable skin. Therefore, both excessive dehydration of the liposomes and excessive hydration of the dosed skin (occlusion) should be avoided in the topical application of liposomal formulations for efficient delivery of hydrocortisone to the skin for a prolonged period of time.
在局部应用含氢化可的松的脂质体后,对氢化可的松的体内皮肤吸收情况进行了研究。将该制剂在有和没有封闭的情况下涂抹于无毛小鼠的皮肤(1.0平方厘米)上(氢化可的松剂量为0.1毫克),并监测药物在皮肤(角质层和有活力的皮肤)中的时间变化情况。在未封闭的条件下,角质层和有活力的皮肤中的药物量在1小时内达到最大值,然后迅速下降。在未封闭情况下制剂完全脱水导致脂质体凝胶化,这可能会阻止药物向皮肤的分配,似乎是迅速下降的一个原因。在封闭条件下,皮肤中的药物量得以维持,尽管与未封闭情况相比随后急剧下降(例如,在1小时时角质层约为1/22,有活力的皮肤约为1/8)。封闭防止脂质体凝胶化似乎是维持皮肤中药物浓度的一个潜在机制。皮肤中药物含量的急剧下降可能归因于氢化可的松这种疏水性药物在封闭情况下从脂质体向保持水合状态的角质层的分配减少。在两种应用条件下,氢化可的松在亲水性有活力的皮肤层中的浓度均明显低于角质层中的浓度,表明这些组织之间的分配是氢化可的松到达有活力的皮肤组织的主要决定因素。药物进入角质层的估计渗透深度不受应用条件的显著影响。这些结果表明,对于将氢化可的松从脂质体长期递送至皮肤而言,过度脱水(未封闭)是不可取的。它们还表明,给药皮肤的水合作用(封闭)对于将氢化可的松从脂质体有效递送至皮肤,尤其是有活力的皮肤而言也并非更可取。因此,在局部应用脂质体制剂以将氢化可的松长时间有效递送至皮肤时,应避免脂质体的过度脱水和给药皮肤的过度水合(封闭)。